Dr. Manhal Izzy, MD

Dr. Izzy practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Izzy's NPI, 1417368770, was assigned on May 8, 2014. Dr. Izzy holds Tennessee license 57561.

Dr. Izzy's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Izzy's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Izzy is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Izzy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Izzy practices, 4 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Izzy's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dmand AI has Dr. Izzy's licenses on file in 2 states: Tennessee and Minnesota.

CMS data shows 364 Medicare services from Dr. Izzy across 7 procedure codes in 2024, for 220 Medicare patients. Medicare paid $27,727 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 220 Medicare patients who saw Dr. Izzy in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Izzy's median patient age at 61, with 52% women.

In 2024, Dr. Izzy wrote 408 Medicare Part D claims for 128 patients. 81% of them were for generic drugs. CMS names the drug for 314 of them, across 10 drugs with 11 or more claims each, at $196,389 in total drug cost. In 2023, CMS named 384 claims across 13 drugs.

Dr. Izzy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Izzy as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 82 papers to Dr. Izzy, published from 2015 to 2025. 2021 was the busiest year, with 17. The most frequent topics are Liver Transplantation, Liver Cirrhosis and Cardiomyopathies. Dr. Izzy has published most often in Liver Transpl. Dr. Izzy's most frequent co-authors are Sophoclis P. Alexopoulos, MD, Lea Kiku Matsuoka, MD and Kymberly D. Watt, MD.

Dmand AI links Dr. Izzy to 1 clinical trial. Conditions studied include Hepatorenal Syndrome and Liver Diseases.

CMS Open Payments shows 44 general payments to Dr. Izzy from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 31% of the total. Madrigal Pharmaceuticals paid the most, $12,310.